AZD8055 Plus Temozolomide Effective for Glioblastoma in Preclinical Study
A novel drug called AZD8055 plus temozolomide extended the life of animals with human brain tumors by 30%.
A novel drug called AZD8055 plus temozolomide extended the life of animals with human brain tumors by 30%.
Researchers have found that miR-181b plays a role in tumor progression and drug resistance.
Scientists have found a new way to diagnose brain cancer based on genetic markers found in “junk DNA.”
A “Trojan horse” treatment for brain cancer has been successfully tested by scientists.
Findings show the key role of a protein called galectin-1 in some of the most dangerous brain tumors.
A team confirmed that tumors grow faster and more frequently from male brain cells.
Previously studied SapC-DOPS could be used for treatment of brain cancer that has spread.
Researchers analyzed the effects of gene therapy, a possible alternative treatment for patients with glioblastoma multiforme.
PARC/CUL9 promotes long-term survival in neurons and brain cancer cells by overriding the biochemical mechanisms that lead to apoptosis.
Invading glioblastoma cells may damage the brain’s protective barrier, a study in mice indicates.